Validation of a new screening strategy for anti-extractable nuclear antigen antibodies

Clinical and Experimental Rheumatology

Volumn 27, Issue 6, 2009, Pages 971-976

  Van Praet, Jens T ^a   Vander Cruyssen, Bert ^a   Bonroy, Carolien ^a   Smith, Vanessa ^a   Delanghe, Joris ^a   De Keyser, Filip ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Anti extractable nuclear antigen antibodies; ROC curve; Sensitivity and specificity; Systemic lupus erythematosus; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ANTIBODY DETECTION; ANTIBODY SCREENING; ANTIGEN ANTIBODY REACTION; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MALE; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCHOOL CHILD; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SERUM; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; ANTIGENS, NUCLEAR; CHILD; CONNECTIVE TISSUE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 76649085203     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. VON MUHLEN CA, TAN EM: Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995; 24: 323-58.
2. HOFFMAN IE, PEENE I, MEHEUS L et al.: Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis 2004; 63: 1155-8.
3. PEENE I, MEHEUS L, VEYS EM, DE KEYSER F: Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 2001; 60: 1131-6.
4. MEHEUS L, VAN VENROOIJ WJ, WIIK A et al.: Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders. Clin Exp Rheumatol 1999; 17: 205-14.
5. ROUQUETTE AM, DESGRUELLES C, LAROCHE P: Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods. Am J Clin Pathol 2003; 120: 676-81.
6. DAMOISEAUX JG, TERVAERT JW: From ANA to ENA: how to proceed? Autoimmun Rev 2006; 5: 10-7.
7. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
8. HOCHBERG MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
9. LEROY EC, MEDSGER TA, JR: Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-6.
10. HARPER R, REEVES B: Reporting of precision of estimates for diagnostic accuracy: a review. BMJ 1999; 318: 1322-3.
11. BIZZARO N, WIIK A: Appropriateness in anti-nuclear antibody testing: From clinical request to strategic laboratory practice. Clin Exp Rheumatol 2004; 22: 349-55.
12. GONZALEZ C, GARCIA-BERROCAL B, PEREZ M, NAVAJO JA, HERRAEZ O, GONZALEZ-BUITRAGO JM: Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients. Clinica Chimica Acta 2005; 359: 109-14.
13. VOS PA, BAST EJ, DERKSEN RH: Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice. Rheumatology 2006; 45: 629-35.
14. POTTEL H, WIIK A, LOCHT H et al.: Clinical optimization and multicenter validation of antigen-specific cut-off values on the INNOLIA ANA update for the detection of autoantibodies in connective tissue disorders. Clin Exp Rheumatol 2004; 22: 579-88.
15. WIIK AS, GORDON TP, KAVANAUGH AF et al.: Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Rheum 2004; 51: 291-8.
16. BIZZARO N, TOZZOLI R, SHOENFELD Y: Are we at a stage to predict autoimmune rheumatic diseases? Arthritis Rheum 2007; 56: 1736-44.